Looker Benjamin

CIK 00018595092 companiesANN ARBOR, MI

SEC Profile

Transactions

Companies

Filings

CIK

0001859509

Recent Transactions

19 trades

Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2026-01-20$2.88/sh−1,689→ 384,216 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2025-12-17$3.67/sh−6,517→ 385,905 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2025-10-17$2.62/sh−1,248→ 392,422 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2025-09-17$2.80/sh−6,267→ 393,670 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2025-07-17$1.13/sh−1,304→ 399,937 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2025-06-17$1.15/sh−6,422→ 401,241 total
Award
Esperion Therapeutics, Inc.$ESPR
Common Stock
2025-03-14+224,000→ 407,663 total
Award
Esperion Therapeutics, Inc.$ESPR
Stock Option (right to buy)
2025-03-14+201,000→ 201,000 total
Award
Esperion Therapeutics, Inc.$ESPR
Stock Option (right to buy)
2024-03-14+150,000→ 150,000 total
Award
Esperion Therapeutics, Inc.$ESPR
Common Stock
2024-03-14+100,000→ 183,663 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2023-04-19$1.27/sh−1,290→ 83,663 total
Award
Esperion Therapeutics, Inc.$ESPR
Common Stock
2023-03-14+20,500→ 84,953 total
Award
Esperion Therapeutics, Inc.$ESPR
Stock Option (right to buy)
2023-03-14+86,900→ 86,900 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2023-01-18$7.00/sh−6,347→ 64,453 total
Award
Esperion Therapeutics, Inc.$ESPR
Stock Option (right to buy)
2022-06-07+52,000→ 52,000 total
Award
Esperion Therapeutics, Inc.$ESPR
Stock Option (right to buy)
2022-01-27+100,450→ 100,450 total
Award
Esperion Therapeutics, Inc.$ESPR
Common Stock
2022-01-27+70,800→ 70,800 total
Disposition to Issuer
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-11-17−190,000→ 0 total
Award
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-05-03+190,000→ 190,000 total

Companies

Recent Filings

Address

C/O ESPERION THERAPEUTICS, INC. 3891 RANCHERO DRIVE, SUITE 150

ANN ARBOR, MI, 48108

View on SEC.gov